CONTEXT AND OBJECTIVE: Celiac disease is an autoimmune disorder with an average prevalence of 1% in Europe and the United States. Because of strong European ancestry in southern Brazil, this study aimed to evaluate the seroprevalence of celiac disease among autoimmune thyroiditis patients. DESIGN AND SETTING: Cross-sectional study in a public university hospital.
INTRODUCTION
Celiac disease is an autoimmune disorder characterized by permanent intolerance to ingested gluten. 1 Once considered rare, celiac disease has a prevalence of approximately 1% in Europe and the United States. 2 In Brazil, the seroprevalence amongst blood donors ranges from 1:417 in the south, to 1:214 -1:286 in São Paulo, and 1:681 in Brasília, possibly explained by the European origin of the population of southern Brazil. [3] [4] [5] [6] Celiac disease is characterized by chronic inflammation of the mucosa of the proximal small intestine, which improves when foods containing gluten are excluded from the diet and relapses when these foods are reintroduced. Structurally, the main features consist of villous atrophy in the small intestine, crypt hyperplasia and inflammatory infiltration of the lamina propria and intraepithelial compartments. The functional changes include reduction in food digestion, decreased absorption of macro and micronutrients and increased secretion of water and solutes. 7 Celiac disease may remain asymptomatic throughout life, or manifest clinically at any time,
with various clinical presentations, such as iron deficiency anemia, chronic diarrhea, abdominal pain or discomfort, weight loss, neurological symptoms, dermatitis herpetiformis, hypoproteinemia, hypocalcaemia and elevated liver enzymes, among others. [8] [9] [10] However, it is increasingly recognized that symptomatic cases represent only the tip of the celiac iceberg. [10] [11] [12] Asymptomatic patients often remain undiagnosed, since screening tests are usually carried out only on patients with typical manifestations of the disease. 11 Undiagnosed celiac disease has been correlated with a fourfold increase in the risk of death. 12 The screening tests include serological tests for anti-endomysial (EMA) and tissue anti-transglutaminase (TTG) immunoglobulin A (IgA) antibodies, which, when positive, are indicative that the patient presents the disease. Although these tests are not conclusive, since histological confirmation is required, investigation of EMA and TTG antibodies is a useful and less invasive tool that enables screening of a great number of people. Thus, these tests can ensure that either asymptomatic individuals or those with mild clinical forms are identified. 13, 14 Patients who are serologically positive for celiac disease and normal histology present its latent form. 
METHODS

Patients
This descriptive cross-sectional prevalence study included all consecutive adult patients with autoimmune thyroid disease seen at the Endocrinology Outpatient Clinic of the University
Hospital of the Federal University of Santa Catarina between
August 2010 and July 2011. They underwent celiac disease screening for this study through investigation of EMA and TTG antibodies, after giving their written informed consent.
Patients without complete clinical and laboratory data registration in their medical records were excluded from the study.
The study protocol conformed to the ethical guidelines of the 1975 Helsinki Declaration and was approved by our institutional review board under the number 857/10.
Methods
Assuming an estimated prevalence rate of 11% for celiac disease among patients with autoimmune thyroiditis 17 and using a 95% confidence interval (CI) and an accuracy of 0.8%, the estimated sample size was 50 individuals. 18 At outpatient consultations, an interview guided by a specific protocol designed for this study was conducted in order to Upper digestive endoscopy and duodenal biopsy was indicated for individuals who were serologically positive for celiac disease.
Duodenal fragments were fixed in 10% formalin, processed with paraffin and stained with hematoxylin-eosin (HE). For diagnosing celiac disease, the following histological variables were analyzed: lymphocytic infiltrate, villous atrophy and crypt hyperplasia.
Statistical analysis
Continuous variables were compared using the Student t test or the Mann-Whitney test when appropriate. Categorical variables were compared using the chi-square or Fisher exact test. P values less than 0.05 were considered statistically significant. All tests were two-tailed and were conducted using the Statistical Package for the Social Sciences (SPSS, Chicago, IL, USA), version 17.0.
RESULTS
Patients' characteristics
Between August 2010 and July 2011, 56 patients with autoimmune thyroid disease were considered for enrollment. Three individuals were excluded from the study because they were not tested for EMA and TTG antibodies (Figure 1 ).
The characteristics of the 53 consecutive patients fulfilling the entry criteria are summarized in Table 1 . Their mean age was 49.0 ± 13.5 (median 51.0) years; 92.5% were women and 87.8% were Caucasian. None of the patients included presented IgA deficiency.
Evaluation of patients who were serologically positive for celiac disease
Five patients out of 53 (9.3%) were serologically positive for celiac disease ( Table 2) Table 1) .
DISCUSSION
Mass screening for celiac disease is not supported by the present evidence. 22 Currently, the best approach is to focus on case findings by screening individuals who are known to have a higher risk of celiac disease. 20 The commercially available diagnostic tests for celiac disease are antigliadin antibody (AGA), EMA and TTG. In comparison with the other tests, AGA presents lower specificity (< 90%), and hence its use is no longer recommended in clinical practice. EMA and TTG IgA antibodies present high sensitivity (97-90%) and specificity (99-95%) for the serological diagnosis of celiac disease. 5 It is well recognized that the combined use of the two antibodies (EMA and TTG) provides greater sensitivity in diagnosing celiac disease, since almost one third of the patients present reactivity for only one of the two antibodies. 23 However, from a practical standpoint, the sensitivity of commercial assays may vary and does not necessarily represent what is described in the literature, especially in subjects with major villous atrophy.
24
IgA deficiency is recognized as a cause of false negative serological results, and this is more common among individuals with celiac disease than in the general population (1:40 versus 1:400). The doses decreased significantly after treatment of celiac disease (154 µg versus 111 µg; P = 0.030). 34 Since it has been demonstrated that celiac disease may be present in patients with hypothyroidism requiring elevated levothyroxine doses, routine screening for celiac disease has been widely proposed for patients with autoimmune thyroid disease. 17, 34, 35 In a study evaluating the presence of celiac disease among individuals with autoimmune thyroiditis, Sari et al. reported that among 101 Turkish children with autoimmune thyroiditis, 7.9%
were positive for IgA TTG. Among five of these individuals who underwent duodenal biopsy, three presented marked subtotal villous atrophy whereas the other two showed normal histology. were positive for AGA and EMA and had celiac disease. 40 Valentino et al. screened 150 patients with autoimmune thyroid disease for celiac antibodies (EMA IgA). Five patients (3.3%) were EMAreactive and all of them exhibited subtotal villous atrophy in jejunal biopsies, thus allowing the diagnosis of celiac disease. 41 Berti et al. reported that the prevalence of celiac disease (EMA IgA reactive and villous atrophy in small-bowel biopsies) was 3.4% among 172 individuals with autoimmune thyroid disease. 42 Mainardi et al.
demonstrated that the prevalence of celiac disease (IgG/IgA AGA, IgA TTG and IgA EMA antibodies and villous atrophy in duodenal biopsies) was 2% among 100 patients with autoimmune thyroiditis. The serological markers became undetectable six months after a gluten-free diet was started. However, thyroid autoantibodies did not positively correlate with dietary habits. 43 Volta et al.
showed that there was higher prevalence of celiac disease (IgA TTG and/or IgA EMA, villous atrophy and intraepithelial lymphocytes > 40%) among 220 individuals with autoimmune thyroiditis than in 250 blood donors (3.2% versus 0.4%; P = 0.022). 44 Both celiac disease and autoimmune thyroiditis are more common among women. 21, 34, 41, 42, 44 This is consistent with the findings in the present study, in which 92.5% of the patients with autoimmune thyroiditis were female. However, the proportion of women found among the patients who were serologically posi- with autoimmune thyroiditis has been described, with mean ages ranging from 54.7 to 60.3 years (overall age range: 26-84). 19, 42, 44 Although it has been reported that the risk of celiac disease in patients with autoimmune thyroiditis increases with age, 19 it is known that celiac antibodies appear earlier than histological and clinical features. 24 Celiac disease was traditionally considered to be a childhood disease, but most patients are now diagnosed in adulthood. It remains unclear why the prevalence of celiac disease seems to have increased over time. 10 A prevalence of celiac disease of 0.1% was demonstrated among elderly Brazilians. 45 Despite the classic presentation in this group, the diagnosis is often delayed because of investigations for colonic neoplasia to explain diarrhea, anemia, weight loss and weakness. 46 In the present study, the median BMI did not differ between subjects with positive and negative serological tests, and both groups had a median BMI greater than 25 kg/m 2 , which classified them as overweight. Although weight loss is a recognized presentation of celiac disease, 6,7 a substantial proportion of patients are overweight. 47 Among 371 individuals with biopsy-proven celiac disease, Dickey et al. 47 showed that 39% were overweight according to the World Health Organization criteria, 48 and 13% were obese. 47 This finding could reflect the absence of clinical manifestations in serologically positive patients (celiac disease in a latent form). 10, 16 Overweight is frequently described as a clinical feature of hypothyroidism; nevertheless, the TSH levels were similar between the two groups (P = 0.351) and the median TSH remained within the normal range, thus suggesting that the disease was compensated in most of the subjects included. This characteristic probably reflects the worldwide trend towards increasing weight, secondary to lifestyle. 49 Between 1975 and 1979, the prevalence of obesity in Brazil increased by 92% for men and 63%
for women. Between 1989 and 2003, obesity rates remained stable among women. 50 The prevalence of obesity reported among Brazilians ranges from 5% to 19%, [51] [52] [53] while in the United States, the prevalence of obesity is 32% among adults, which is much higher than reported elsewhere. 54 In that country, Cheng et al.
evaluated 369 individuals with celiac disease and showed that 15.2% of them presented overweight and 6.8% were obese. 55 Diarrhea is the most common clinical manifestation of celiac disease; however, it is present in less than 50% of the cases. [8] [9] [10] In the present study, 20% of the individuals who were serologically positive for celiac disease presented diarrhea, and its prevalence did not differ between the two groups. Since this was a screening study, it was expected that individuals who were serologically positive for celiac disease would mostly be asymptomatic. Among the studies that evaluated the prevalence of celiac disease in patients with autoimmune thyroid disease, most patients did not show symptoms. 37, 41, 42 Serum ferritin is a secretory component synthesized from intracellular ferritin, which reflects an individual's iron reserves.
Hypoferritinemia can be found in cases of iron deficiency, through decreased inventories of this mineral, and also in cases of scurvy and hypothyroidism. In the latter, it occurs through decreased synthesis of serum ferritin. High iron stores are associated with higher levels of plasma ferritin, but hyperferritinemia may also be observed in states of inflammation, cancer, tissue damage and increased metabolism, which make proteins sensitive to but not very specific for assessing the iron balance. 56 Transferrin is the principal iron transport protein in the extracellular compartment. When there is a large amount of stored iron, there is less transferrin production, and its saturation reflects the iron stores. 57 Among 13 individuals with autoimmune thyroiditis and celiac disease, Meloni et al. observed hypoferritinemia in 46% of them. 32 In the present study, all the individuals who were serologically positive for celiac disease presented hypoferritinemia. In comparison with the other individuals, the serum levels of ferritin were lower, but this difference was not statistically significant. Rather, the hemoglobin level was higher among serologically positive individuals, possibly because the proportion of men was higher, given that men are known to have higher hemoglobin levels than women. 57 Future studies should compare celiac disease prevalence between healthy individuals and those with autoimmune thyroid disease. It would also be of great interest to evaluate the influence of a gluten-free diet on thyroid disease treatment and TSH control, among individuals with both diseases.
CONCLUSION
The prevalence of celiac disease among patients with autoimmune thyroid disease was 9.3%. One person complained of diarrhea and none of the patients presented anemia. In comparison with other individuals, the group of patients who were serologically positive for celiac disease presented lower median age, a lower proportion of females and higher median hemoglobin levels. In at-risk populations, such as patients with autoimmune thyroid disease, signs and symptoms such as anemia and diarrhea
should not be used as criteria for celiac disease screening. Celiac antibodies ought to be tested in all subjects with autoimmune thyroiditis, because of its high prevalence.
